sotorasib,durvalumab,tremelimumab,nivolumab,ipilimumab
amgen,astrazeneca,pfizer,bms
['poseidon', 'nsclc', 'sclc', 'codebreak200', 'lcsm,(-blcsm)']
day 4 #esmo22 highlights from #communityoncologists perspective: 1. #ifct1701 - ici in mnsclc 2. #poseidon update - mnsclc 3. #codebreak200 - kras g12c nsclc #lcsm #medtwitter #onced 1/9
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.